EU CHMP Recommends Marketing Authorisation for Rasonque
The EMA’s Committee for Medicinal Products for Human Use recommended granting marketing authorisation for Rasonque for metastatic pancreatic cancer in the EU.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.